Literature DB >> 3183688

Cardiovascular risk factor change--1973-74 to 1980-82: the Minnesota Heart Survey.

R V Luepker1, D R Jacobs, A R Folsom, R F Gillum, I D Frantz, O Gomez, H Blackburn.   

Abstract

Reductions in population risk factor levels, including blood pressure, blood cholesterol, and cigarette smoking may be associated with the observed decline in cardiovascular disease (CVD) mortality rates. However, few recent population-based comparisons of risk trends are available. To evaluate changes in these risk characteristics in the recent period, data were compared from two surveys performed in the same metropolitan area using similar methods. The Lipid Research Clinic (LRC) Prevalence Study surveyed a population sample of 4185 adults aged 25-59 in 1973-74. The Minnesota Heart Survey (MHS) surveyed a population sample of 2914 adults of the same age in the same metropolitan area in 1980-82. The average systolic and diastolic blood pressures were significantly lower in the 1980-82 survey averaging 1.5/3.8 mmHg for men and 1.6/2.8 mmHg for women. The use of anti-hypertensive medications increased significantly over the period while the prevalence of hypertension was similar. Significant declines in mean serum cholesterol were also observed in 1980-82, averaging 3.3 mg/dl for men and 5.5 mg/dl women. The prevalence of regular cigarette smoking in men was also lower in 1980-82, 36.3 vs 42.1% in 1973-74. Women had a lower prevalence of smoking (38.8-35.6%) but the average woman smoker increased consumption of cigarettes while the average man did not. These observations suggest that population risk defined by these characteristics is declining which may explain part of recent Minnesota trends in CVD mortality and could have a favorable effect on future disease patterns.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3183688     DOI: 10.1016/0895-4356(88)90098-4

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  8 in total

1.  Evaluating South Carolina's community cardiovascular disease prevention project.

Authors:  F C Wheeler; D T Lackland; M L Mace; A Reddick; G Hogelin; P L Remington
Journal:  Public Health Rep       Date:  1991 Sep-Oct       Impact factor: 2.792

2.  Prevalence, control and awareness of high blood pressure among Canadian adults. Canadian Heart Health Surveys Research Group.

Authors:  M R Joffres; P Hamet; S W Rabkin; D Gelskey; K Hogan; G Fodor
Journal:  CMAJ       Date:  1992-06-01       Impact factor: 8.262

3.  Trends in blood pressure and hypertension detection, treatment, and control 1980 to 2009: the Minnesota Heart Survey.

Authors:  Russell V Luepker; Lyn M Steffen; David R Jacobs; Xia Zhou; Henry Blackburn
Journal:  Circulation       Date:  2012-09-07       Impact factor: 29.690

4.  Critical decision analysis for extracranial cerebrovascular disease.

Authors:  T J Takach; D A Ott; G J Reul; D A Cooley
Journal:  Tex Heart Inst J       Date:  1996

5.  Trends in blood pressure and the prevalence and treatment of hypertension in young adults in The Netherlands, 1974-1986.

Authors:  E M van Leer; W M Verschuren; D Kromhout
Journal:  Eur J Epidemiol       Date:  1994-04       Impact factor: 8.082

6.  Trends in fatty acid intake of adults in the Minneapolis-St Paul, MN Metropolitan Area, 1980-1982 through 2007-2009.

Authors:  Mary Ann Honors; Lisa J Harnack; Xia Zhou; Lyn M Steffen
Journal:  J Am Heart Assoc       Date:  2014-10-22       Impact factor: 5.501

7.  Twenty-two-year population trends in sodium and potassium consumption: the Minnesota Heart Survey.

Authors:  Katie A Meyer; Lisa J Harnack; Russell V Luepker; Xia Zhou; David R Jacobs; Lyn M Steffen
Journal:  J Am Heart Assoc       Date:  2013-10-02       Impact factor: 5.501

8.  Population Trends in Aspirin Use for Cardiovascular Disease Prevention 1980-2009: The Minnesota Heart Survey.

Authors:  Russell V Luepker; Lyn M Steffen; Sue Duval; Nicole D Zantek; Xia Zhou; Alan T Hirsch
Journal:  J Am Heart Assoc       Date:  2015-12-23       Impact factor: 5.501

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.